North Grafton, MA, United States of America

Deborah Alexa Sirko-Osadsa

This inventor holds 5 USPTO granted patents. Top assignee: Laboratory Corporation of America Holdings. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah Alexa Sirko-Osadsa. Retrieved from https://idiyas.com/inventor/deborah-alexa-sirko-osadsa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Deborah Alexa Sirko-Osadsa

Introduction

Deborah Alexa Sirko-Osadsa is a prominent inventor based in North Grafton, MA (US). She has made significant contributions to the field of genetics, particularly in the study of cystic fibrosis. With a total of five patents to her name, her work has advanced the understanding and diagnosis of this genetic disorder.

Latest Patents

One of her latest patents focuses on mutations associated with cystic fibrosis. This invention provides novel mutations identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations can be utilized for a more accurate diagnosis of cystic fibrosis (CF) and CF-related disorders. The patent outlines methods for testing a sample obtained from a subject to determine the presence of one or more mutations in the CFTR gene. The presence of these mutations indicates that the subject has CF, a CF-related disorder, or is a carrier of a CFTR mutation.

Career Highlights

Deborah works at Laboratory Corporation of America Holdings, where she continues to innovate and contribute to the field of genetic research. Her expertise and dedication have positioned her as a key figure in the development of diagnostic methods for cystic fibrosis.

Collaborations

She collaborates with notable colleagues, including Elizabeth Rohlfs and Lynne Rosenblum, who share her commitment to advancing medical science and improving patient outcomes.

Conclusion

Deborah Alexa Sirko-Osadsa's work exemplifies the impact of innovation in the medical field, particularly in the diagnosis and understanding of cystic fibrosis. Her contributions are invaluable to both the scientific community and patients affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…